Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer

In recent years, studies have explored different combinations of immunotherapy and chemotherapy. The rationale behind these is the improved survival outcomes of new immunologic therapies used in first-line-treatment of advanced non-small cell lung cancer. Moreover, for the most-studied combinations...

Descripción completa

Detalles Bibliográficos
Autores principales: Sereno, María, Higuera, Oliver, Cruz Castellanos, Patricia, Falagan, Sandra, Mielgo-Rubio, Xabier, Trujillo-Reyes, Juan Carlos, Couñago, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716995/
https://www.ncbi.nlm.nih.gov/pubmed/35070737
http://dx.doi.org/10.5306/wjco.v12.i12.1182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716995/
https://www.ncbi.nlm.nih.gov/pubmed/35070737
http://dx.doi.org/10.5306/wjco.v12.i12.1182

Ejemplares similares